Pathological Complete Response: Clinical Trials

1 trial for Pathological Complete Response, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1

Follow Pathological Complete Response: new trials by email Literature Review of Pathological Complete Response trials Research Report on Pathological Complete Response

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
Sintilimab combined with XELOX - Pathological Complete Response, Rectal Cancer
Phase 2Active not recruitingThe First Affiliated Hospital of Anhui Medical University502022-06-012025-11-21

Narrower conditions

Rectal Neoplasms (1)

Broader conditions

Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Rectal Diseases (1)

Interventions

XELOX (1)

Sponsors

The First Affiliated Hospital of Anhui Medical University (1)

Countries

China (1)